Results showed that people diagnosed with diabetes as adults had a higher risk of heart disease, as well as premature death from any cause, including cancer and infections. Specifically, type 1 ...

Diabetes is a chronic, lifelong, and irreversible condition where the body is unable to control blood sugar levels. It occurs ...

Netherlands: A new study published in Diabetes, Obesity and Metabolism highlights the long-term benefits of intermittently ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

In 2024, 4% of U.S. adults were prescribed a GLP-1 therapy — a 363.7% increase from 0.9% in 2019, according to a Fair Health analysis of more than 51 billion commercial claim records.  Fair Health ...

The results were quite surprising. They found that people who took GLP-1 agonists had a 30% lower risk of developing dementia ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of ...

As temperatures drop, many people living with diabetes may find their usual routines disrupted. Cold weather, seasonal ...